Clinical characteristics of breast cancer in patients with an NBS1 mutation

Breast Cancer Research and Treatment

Volumn 141, Issue 3, 2013, Pages 471-476

  Huzarski, T ^a   Cybulski, C ^a   Jakubowska, A ^a   Byrski, T ^a   Gronwald, J ^a   Domagala P ^a   Szwiec, M ^b   Godlewski, D ^c   Kilar, E ^d   Marczyk, E ^e   Siolek M ^f   Gorski, B ^a   Wianiowski R ^g   Janiszewska, H ^h   Surdyka, D ⁱ   Sibilski, R ^j   Sun, P ^k   Narod, S A ^k   Lubinski J ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b Regional Oncology Center   (Poland)

^c OPEN   (Poland)

^d Department of Pathology   (Poland)

^e INSTITUTE OF ONCOLOGY   (Poland)

^f Regional Oncology Center   (Poland)

^g Regional Oncology Hospital   (Poland)

^h NICOLAUS COPERNICUS UNIVERSITY   (Poland)

ⁱ ST JOHN S CANCER CENTER   (Poland)

^j Oncology Center   (Poland)

^k WOMEN S COLLEGE HOSPITAL   (Canada)

more..

Author keywords

Breast cancer; NBS1; Prognostic factors; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; NIBRIN; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOUNDER EFFECT; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NBS1 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME;

ADULT; BREAST NEOPLASMS; CELL CYCLE PROTEINS; FEMALE; FOUNDER EFFECT; GENETIC ASSOCIATION STUDIES; HUMANS; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK; YOUNG ADULT;

EID: 84887103127     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2692-x     Document Type: Article

References (13)

1. Futaki M, Lui JM (2001) Chromosome breakage syndromes and the BRCA1 genome surveillance complex. Trends Mol Med 7:560-565
2. Carney JP, Maser RS, Olivares H, Davis EM, Le Beau M, Yates JR 3rd, Hays L, Morgan WF, Petrini JH (1998) The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 93:477-486
3. Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrzanowska KH, Saar K, Beckmann G, Seemanova E, Cooper PR, Nowak NJ, Stumm M, Weemaes CM, Gatti RA, Wilson RK, Digweed M, Rosenthal A, Sperling K, Concannon P, Reis A (1998) Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93:467-476
4. Varon R, Seemanova E, Chrzanowska K, Hnateyko O, Piekutowska-Abramczuk D, Krajewska-Walasek M, Sykut-Cegielska J, Sperling K, Reis A (2000) Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations. Eur J Hum Genet 8:900-902
5. Górski B, Dȩbniak T, Masojć B, Mierzejewski M, Mȩdrek K, Cybulski C, Jakubowska A, Kurzawki G, Chosia M, Scott RJ, Lubiński J (2003) Germline 657del5 mutation in the NBS1 gene in breast cancer patients. Int J Cancer 106:379-381
6. Steffen J, Varon R, Mosor M, Maneva G, Maurer M, Stumm M, Nowakowska D, Rubach M, Kosakowska E, Ruka W, Nowecki Z, Rutkowski P, Demkow T, Sadowska M, Bidziński M, Gawrychowski K, Sperling K (2004) Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. Int J Cancer 11:67-71
7. Steffen J, Nowakowska D, Niwińska A, Czapczak D, Kluska A, Piatkowska M, Wisniewska A, Paszko Z (2006) Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland. Int J Cancer 119:472-475
8. Buslov KG, Iyevleva AG, Chekmariova EV, Suspitsin EN, Togo AV, Kuligina ESh, Sokolenko AP, Matsko DE, Turkevich EA, Lazareva YR, Chagunava OL, Bit-Sava EM, Semiglazov VF, Devilee P, Cornelisse C, Hanson KP, Imyanitov EN (2005) NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia. Int J Cancer 114:585-589
9. Cybulski C, Górski B, Debniak T, Gliniewicz B, Mierzejewski M, Masojć B, Jakubowska A, Matyjasik J, Złowocka E, Sikorski A, Narod SA, Lubiński J (2004) NBS1 is a prostate cancer susceptibility gene. Cancer Res 64:1215-1219
10. Hebbring SJ, Fredriksson H, White KA, Maier C, Ewing C, McDonnell SK, Jacobsen SJ, Cerhan J, Schaid DJ, Ikonen T, Autio V, Tammela TL, Herkommer K, Paiss T, Vogel W, Gielzak M, Sauvageot J, Schleutker J, Cooney KA, Isaacs W, Thibodeau SN (2006) Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer. Cancer Epidemiol Biomarkers Prev 15:935-938
11. Bogdanova N, Feshchenko S, Schürmann P, Waltes R, Wieland B, Hillemanns P, Rogov YI, Dammann O, Bremer M, Karstens JH, Sohn C, Varon R, Dörk T (2008) Nijmegen Breakage Syndrome mutations and risk of breast cancer. Int J Cancer 122:802-806
12. Cybulski C, Wokołorczyk D, KluÅoniak W, Jakubowska A, Górski B, Gronwald J, Huzarski T, Kashyap A, Byrski T, Dȩbniak T, Goła̧b A, Gliniewicz B, Sikorski A, Switała J, Borkowski T, Borkowski A, Antczak A, Wojnar L, Przybyła J, Sosnowski M, Małkiewicz B, Zdrojowy R, Sikorska-Radek P, Matych J, Wilkosz J, Rózański W, KiÅ J, Bar K, Bryniarski P, Paradysz A, Jersak K, Niemirowicz J, Słupski P, Jarzemski P, Skrzypczyk M, Dobruch J, Domagała P, Narod SA, Lubiński J, Polish Hereditary Prostate Cancer Consortium (2013) An inherited NBN mutation is associated with poor prognosis prostate cancer. Br J Cancer 108:461-468
13. Górski B, Cybulski C, Huzarski T, Byrski T, Gronwald J, Jakubowska A, Stawicka M, Gozdecka-Grodecka S, Szwiec M, Urbański K, MituÅ J, Marczyk E, Dziuba J, Wandzel P, Surdyka D, Haus O, Janiszewska H, Debniak T, Tołoczko-Grabarek A, Medrek K, Masojć B, Mierzejewski M, Kowalska E, Narod SA, Lubiński J (2005) Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat 92:19-24